Literature DB >> 16838306

Down syndrome: common otolaryngologic manifestations.

Sally R Shott1.   

Abstract

Otolaryngologic or ear, nose, and throat (ENT) problems are common in children with Down Syndrome (DS). This includes problems with chronic ear infections and chronic middle ear effusions with associated hearing loss, airway obstruction, and sleep apnea, as well as problems with chronic rhinitis and sinusitis. In addition, many of these ENT problems require surgical interventions, and there are special anesthesia considerations that need to be addressed in children with DS. These include subglottic stenosis, post-operative airway obstruction, and cervical spine concerns. As the care of children with DS has become more consistent and proactive, outcomes from the treatment of these ENT manifestations have improved. Aggressive interventions, both medical and surgical, have led to a decreased incidence of hearing loss, good control of the chronic rhinitis, and a better awareness of the incidence of sleep apnea and sleep-disordered breathing in individuals with DS. These common otolaryngologic manifestations of DS are reviewed with recommendations for ongoing care and monitoring.

Entities:  

Mesh:

Year:  2006        PMID: 16838306     DOI: 10.1002/ajmg.c.30095

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  36 in total

Review 1.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

2.  Convergent validity of actigraphy with polysomnography and parent reports when measuring sleep in children with Down syndrome.

Authors:  A J Esbensen; E K Hoffman; E Stansberry; R Shaffer
Journal:  J Intellect Disabil Res       Date:  2018-01-05

3.  Prevalence of Obstructive Sleep Apnea in Children With Down Syndrome: A Meta-Analysis.

Authors:  Chia-Fan Lee; Chia-Hsuan Lee; Wan-Yi Hsueh; Ming-Tzer Lin; Kun-Tai Kang
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

4.  Health and problem behavior among people with intellectual disabilities.

Authors:  Michael E May; Craig H Kennedy
Journal:  Behav Anal Pract       Date:  2010

5.  A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.

Authors:  Randall J Roper; Justin F VanHorn; Colyn C Cain; Roger H Reeves
Journal:  Mech Dev       Date:  2008-11-21       Impact factor: 1.882

6.  Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome.

Authors:  Maria A Stanley; Nicole Shepherd; Nichole Duvall; Sandra B Jenkinson; Hasnaa E Jalou; Deborah C Givan; Gregory H Steele; Charlene Davis; Marilyn J Bull; Donna U Watkins; Randall J Roper
Journal:  Am J Med Genet A       Date:  2018-12-27       Impact factor: 2.802

7.  A cross-sectional analysis of otitis media with effusion in children with Down syndrome.

Authors:  M Maris; M Wojciechowski; P Van de Heyning; An Boudewyns
Journal:  Eur J Pediatr       Date:  2014-05-10       Impact factor: 3.183

8.  Wideband acoustic immittance in children with Down syndrome: prediction of middle-ear dysfunction, conductive hearing loss and patent PE tubes.

Authors:  Lisa L Hunter; Douglas H Keefe; M Patrick Feeney; David K Brown; Jareen Meinzen-Derr; Alaaeldin M Elsayed; Julia M Amann; Vairavan Manickam; Denis Fitzpatrick; Sally R Shott
Journal:  Int J Audiol       Date:  2017-04-22       Impact factor: 2.117

9.  Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome.

Authors:  Mieke Maris; Stijn Verhulst; Marek Wojciechowski; Paul Van de Heyning; An Boudewyns
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

10.  Otitis media in a mouse model for Down syndrome.

Authors:  Fengchan Han; Heping Yu; Jiangping Zhang; Cong Tian; Cecilia Schmidt; Casey Nava; Muriel T Davisson; Qing Y Zheng
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.